by jowen | Sep 29, 2018 | Cancer, Glucans
Ross Immunopharmacology 1999 — Article details beta Glucans mode of action on the immune system. Article describes how CR3 binding by beta Glucan begins a broad immune response especially to cancer tumor cells which the immune system might ordinarily only partially...
by jowen | Sep 29, 2018 | Immunotherapy, Prostate Hyperplasia
Pathology Discovery – 2014 – Volume 2/Article 8 — Article researches the effects of oral beta glucan on benign prostate hyperplasia. Initial findings show an improvement of NK cell numbers and positive effects on the PSA indices. Further support is provided by way of...
by jowen | Sep 28, 2018 | Cancer, Immunity/Immune Response/Immune Response
Clin. Exp. Immunol. 1999 — Article demonstrates that beta glucan’s CR3 binding properties can be effective against cancer tumor cells that do not have CR3 receptor sites by potentiating natural killer (NK) cells to see the tumor cells as non-self. Read...
